NANOTEMPER
LIVE

Serial Number

85040691

Owner

NanoTemper Technologies GmbH

Attorney

Brian J. Focarino

Filing Date

May 17, 2010

Add to watchlist:

No watchlists yet
View on USPTO

NANOTEMPER Trademark

Serial Number: 85040691 • Registration: 4223921

NANOTEMPER is a trademark filed by NanoTemper Technologies GmbH on May 17, 2010. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

NanoTemper Technologies GmbH (12 trademarks)

Floessergasse 4
81369 München , DE

Entity Type: 99

Trademark Details

Filing Date

May 17, 2010

Registration Date

October 16, 2012

Published for Opposition

January 3, 2012

Goods & Services

Scientific apparatus, namely, electro-optical instruments for measurement of fluorescence, comprising a fluorescence excitation light source, optical mirrors, an optical detector and an infrared light source for research and diagnostic purposes; data processors and part therefore; computer hardware; computer software for data collection and data evaluation, database management and automated, semi automated and manual data processing; analytical devices, namely, clinical laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; scientific apparatus, namely, optical instruments that use fluorescence; computer operating systems for the collection and administration of diagnostically or medically relevant data; downloadable electronic publications in the nature of handbooks, manuals, informational and marketing material that are published electronically or as hardcopy in the field of science, diagnostics, pharmaceutical development, food or agricultural technology

[ Pharmaceutical preparations for the treatment and detection of cardiovascular diseases, the gout, heart rhythm disorders, lung diseases, thymus gland diseases, tumors, skin disorders, fecal occult blood, diabetes, inflammation, auto-immune diseases and endocrinological diseases; veterinary preparations for the treatment of cats, dogs, cows, horses snakes, fishes; sanitary preparations for medical use; diagnostic kits consisting primarily of monoclonal antibodies, buffers and reagents for use in disease testing; diagnostic preparations for medical or veterinary use, namely, nucleic acids, proteins, macromolecules and biologically active substances for diagnostic purposes; reagents and media, namely, solvents, buffers, nucleic acids, proteins, macromolecules and biologically active substances for medical and veterinary diagnostic purposes; drug testing kits comprised of medical diagnostic reagents, assays, nucleic acids, proteins, macromolecules and biologically active substances for testing body fluids; medicaments for treating skin disorders, internal illnesses, drug target compositions for treating cardiovascular diseases, the gout, heart rhythm disorders, lung diseases, thymus gland diseases, tumors, skin disorders, fecal occult blood, diabetes, inflammation, auto-immune diseases and other endocrinological or internal diseases; diagnostic kits consisting primarily of monoclonal antibodies, buffers and reagents for use in disease testing; drug testing kits comprised of medical diagnostic reagents and assays for testing bodily fluids; in vitro gender prediction test kits; in vitro ovulation prediction test kit for home use ]

Chemicals used in industry, science and agriculture; [ chemical substances for preserving foodstuffs; ] biochemical compounds, namely, peptides, peptide derivatives, proteins, antibodies, fragments of antibodies, derivatives of antibodies, nucleic acids, vectors, cells, cellular components, micro particles used to detect and analyze interactions, enzymatic processes, toxins, diseases for laboratory and research use; diagnostic kits, consisting primarily of [ monoclonal antibodies, ] buffers and reagent to monitor toxicity of drugs

[ Surgical apparatus and instruments for medical, dental or veterinary use; artificial limbs, eyes, and teeth; medical, namely, orthopedic apparatus and instruments; suture materials; medical products, namely, biofeedback sensors; diagnostic apparatus for the detection of cancer; sample preparation device for medical diagnostic uses ]

Scientific research and technological services, namely, interaction studies, binding studies, activity studies, specificity studies of biomolecules in the field of basic research, industrial research, life sciences, biology, biochemistry, drug development, biotechnology, food technology research in the field of genetics, proteomics, metabolonomics; design and development of computer hardware and software; medical, biological, molecular genetic, chemical, diagnostic, food technological and pharmaceutical research; scientific laboratory services; biochemical, biological, molecular genetic, food technological and diagnostic consulting for scientific purposes; diagnostic services in the field of electro-optical instruments for measurement of fluorescence, comprising a fluorescence excitation light source, optical mirrors, an optical detector and an infrared light source; pharmaceutical drug development services; medical and scientific research, namely, conducting, medical, biological, molecular genetic, chemical, diagnostic, food technological and pharmaceutical research; biochemical, biological, molecular genetic, food technological and diagnostic consulting for scientific purposes; computer programming; design and maintenance of computer software; updating of database software; development of computer software systems for the collection of relevant biological data, namely, interaction mapping, inhibitor classification; Scientific and industrial research, namely, collection, processing, propagation and analysis of biomaterials and medically or diagnostically relevant data

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 28, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
May 28, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 28, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 28, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 28, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 28, 2025 COAR
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Oct 15, 2022 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Oct 15, 2022 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Oct 15, 2022 89AG
TEAS SECTION 8 & 9 RECEIVED
Oct 13, 2022 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Oct 16, 2021 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Oct 30, 2018 NA85
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Oct 30, 2018 C15P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 30, 2018 APRE
TEAS SECTION 8 & 15 RECEIVED
Oct 15, 2018 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Oct 16, 2017 REM1
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 9, 2017 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 9, 2017 REAP
REGISTERED-PRINCIPAL REGISTER
Oct 16, 2012 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Sep 6, 2012 DP1B
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 29, 2012 AITU
NOTICE OF ALLOWANCE CANCELLED
Aug 28, 2012 IUCN
TEAS DELETE 1(B) BASIS RECEIVED
Aug 28, 2012 D1BR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 28, 2012 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 3, 2012 NPUB
PUBLISHED FOR OPPOSITION
Jan 3, 2012 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 14, 2011 NONP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 30, 2011 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 30, 2011 COAR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 29, 2011 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 22, 2011 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 22, 2011 XAEC
EXAMINER'S AMENDMENT ENTERED
Nov 22, 2011 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 22, 2011 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 22, 2011 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 22, 2011 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Nov 22, 2011 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Nov 14, 2011 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 3, 2011 PREV
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 2, 2011 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 2, 2011 COAR
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 1, 2011 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 1, 2011 XAEC
EXAMINER'S AMENDMENT ENTERED
Nov 1, 2011 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 1, 2011 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 1, 2011 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 1, 2011 CNEA
DATA MODIFICATION COMPLETED
Oct 28, 2011 DMCC
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 25, 2011 GNFN
FINAL REFUSAL E-MAILED
Apr 25, 2011 GNFR
FINAL REFUSAL WRITTEN
Apr 25, 2011 CNFR
AMENDMENT FROM APPLICANT ENTERED
Mar 29, 2011 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 29, 2011 CRFA
ASSIGNED TO LIE
Mar 22, 2011 ALIE
PAPER RECEIVED
Mar 10, 2011 MAIL
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 7, 2010 GNRN
NON-FINAL ACTION E-MAILED
Sep 7, 2010 GNRT
NON-FINAL ACTION WRITTEN
Sep 7, 2010 CNRT
ASSIGNED TO EXAMINER
Aug 30, 2010 DOCK
NOTICE OF PSEUDO MARK MAILED
May 27, 2010 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 26, 2010 NWOS
NEW APPLICATION ENTERED
May 20, 2010 NWAP